Skip to content
★ Sign in to follow
DE

Donald E. Saunders

Board Director
Director
Total declarations
59
Company
1
▲ Purchases (4 ops.)
€58k
▼ Sales (37 ops.)
€2.7M

Latest filing published 17 May 2022 for CHEMED CORP, €125k.

Filing timeline

BuySale
Donald E. Saunders

Insider track record

Disclosed buys
4
Disclosed sells
37
Signal history

Closed purchases

Market purchases
4
Positive at T+90
50%
Median T+90
+0.4%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 05 May 2017 · 3474 days ago · €18k
    +54.2%
    Entry US$204.32 · Close at T+365 US$314.98
  • Filed 17 May 2016 · 3827 days ago · €8,610
    +53.4%
    Entry US$128.65 · Close at T+365 US$197.31

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Donald E. Saunders: trading record in brief

Donald E. Saunders, listed as board member, appears in our data through filings on Chemed Corp shares, published by SEC (Form 4). In total, 59 filings cover trades dated from 15 May 2006 to 16 May 2022.

On the open market, the record shows 4 purchases worth €58k and 37 sales worth €2.7M. Netting one side against the other leaves €2.6M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 17 share grants. So far in 2022, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €15k.

The latest filing, published on 17 May 2022, reports a share grant of €125k in Chemed Corp. The clock since the last published purchase (12 May 2020) now reads 2,371 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Donald E. Saunders

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations49 total
  • ◆
    DirectorExecutivesChemed Corp
    130,018 USD13SEC
    262 shares@ US$496.2518.0% of flowcapital stockSEC:0001209191-22-029535:0
  • ▼
    DirectorExecutivesChemed Corp
    211,098 USD14SEC
    405 shares@ US$521.2328.1% of flowcapital stockSEC:0001209191-22-024393:0
  • ▼
    DirectorExecutivesChemed Corp
    117,983 USD11SEC
    221 shares@ US$533.863.5% of flowcapital stockSEC:0001209191-21-071444:1
  • ▼
    DirectorExecutivesChemed Corp
    148,230 USD13SEC
    279 shares@ US$531.2918.9% of flowcapital stockSEC:0001209191-21-071444:0
  • ▼
    DirectorExecutivesChemed Corp
    151,590 USD31SEC
    300 shares@ US$505.3019.4% of flowcapital stockSEC:0001209191-21-065389:0
  • ◆
    DirectorExecutivesChemed Corp
    130,318 USD13SEC
    270 shares@ US$482.6615.5% of flowcapital stockSEC:0001209191-21-033413:0
  • ▼
    DirectorExecutivesChemed Corp
    268,490 USD27SEC
    510 shares@ US$526.4515.3% of flowcapital stockSEC:0001209191-20-065142:0
  • ▼
    DirectorExecutivesChemed Corp
    142,659 USD32SEC
    300 shares@ US$475.539.1% of flowcapital stockSEC:0001209191-20-031202:0
  • ◆
    DirectorExecutivesChemed Corp
    130,134 USD14SEC
    279 shares@ US$466.438.3% of flowcapital stockSEC:0001209191-20-030345:0
  • ▼
    DirectorExecutivesChemed Corp
    132,330 USD27SEC
    300 shares@ US$441.108.6% of flowcapital stockSEC:0001209191-20-028451:0
  • ▲
    DirectorExecutivesChemed Corp
    21,148 USD0SEC
    49 shares@ US$431.601.4% of flowcapital stockSEC:0001209191-20-028451:1
    Canonical exit: 9 Aug 2020 (T+90)
  • ▼
    DirectorExecutivesChemed Corp
    93,956 USD12SEC
    200 shares@ US$469.785.5% of flowcapital stockSEC:0001209191-20-013289:0
  • ▼
    DirectorExecutivesChemed Corp
    46,891 USD11SEC
    100 shares@ US$468.912.7% of flowcapital stockSEC:0001209191-20-013289:1
  • ▼
    DirectorExecutivesChemed Corp
    129,897 USD30SEC
    300 shares@ US$432.995.2% of flowcapital stockSEC:0001209191-19-045857:0
  • ▼
    DirectorExecutivesChemed Corp
    43,250 USD29SEC
    100 shares@ US$432.501.7% of flowcapital stockSEC:0001209191-19-045857:1
  • ◆
    DirectorExecutivesChemed Corp
    85,244 USD11SEC
    257 shares@ US$331.693.4% of flowcapital stockSEC:0001209191-19-031942:0
  • ▼
    DirectorExecutivesChemed Corp
    131,424 USD31SEC
    400 shares@ US$328.564.9% of flowcapital stockSEC:0001209191-19-020968:0
  • ▼
    DirectorExecutivesChemed Corp
    132,136 USD28SEC
    400 shares@ US$330.345.0% of flowcapital stockSEC:0001209191-19-012881:0
  • ▼
    DirectorExecutivesChemed Corp
    92,622 USD28SEC
    300 shares@ US$308.743.3% of flowcapital stockSEC:0001209191-18-057924:0
  • ▼
    DirectorExecutivesChemed Corp
    47,888 USD13SEC
    150 shares@ US$319.251.6% of flowcapital stockSEC:0001209191-18-048136:0
  • ▼
    DirectorExecutivesChemed Corp
    47,879 USD13SEC
    150 shares@ US$319.191.6% of flowcapital stockSEC:0001209191-18-048136:1
  • ◆
    DirectorExecutivesChemed Corp
    85,106 USD13SEC
    255 shares@ US$333.752.5% of flowcapital stockSEC:0001209191-18-032528:0
  • ▼
    DirectorExecutivesChemed Corp
    76,625 USD31SEC
    250 shares@ US$306.502.2% of flowcapital stockSEC:0001209191-18-026455:0
  • ▼
    DirectorExecutivesChemed Corp
    45,966 USD31SEC
    150 shares@ US$306.441.3% of flowcapital stockSEC:0001209191-18-026455:1
  • ▲
    DirectorExecutivesChemed Corp
    14,727 USD0SEC
    48 shares@ US$306.810.4% of flowcapital stockSEC:0001209191-18-026455:2
    Canonical exit: 25 Jul 2018 (T+90)

25 of 49 declarations